Conversely, NKG2D expression levels significantly increased as a result of combined treatment with IL-15 and IL-21, suggesting that the NK cell populations obtained under these culture conditions may represent suitable effectors for cell-based anti-tumour therapeutic approaches. The gene discussed is KLRK1; the disease is neoplasm.